These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32592523)

  • 1. Intrauterine Devices in the Context of Gonococcal Infection, Chlamydial Infection, and Pelvic Inflammatory Disease: Not Mutually Exclusive.
    Esposito CP
    J Midwifery Womens Health; 2020 Jul; 65(4):562-566. PubMed ID: 32592523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.
    Sufrin CB; Postlethwaite D; Armstrong MA; Merchant M; Wendt JM; Steinauer JE
    Obstet Gynecol; 2012 Dec; 120(6):1314-21. PubMed ID: 23168755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections.
    Jatlaoui TC; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):701-712. PubMed ID: 27263041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
    Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
    Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users.
    Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
    J Womens Health (Larchmt); 2015 May; 24(5):354-9. PubMed ID: 25836384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gonococcal pelvic inflammatory disease.
    Curran JW
    Sex Transm Dis; 1979; 6(2 Suppl):174-80. PubMed ID: 115099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception.
    Avonts D; Sercu M; Heyerick P; Vandermeeren I; Piot P
    J R Coll Gen Pract; 1989 Oct; 39(327):418-20. PubMed ID: 2560023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection.
    Lycke E; Löwhagen GB; Hallhagen G; Johannisson G; Ramstedt K
    Sex Transm Dis; 1980; 7(1):6-10. PubMed ID: 6771879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.
    Grentzer JM; Peipert JF; Zhao Q; McNicholas C; Secura GM; Madden T
    Contraception; 2015 Oct; 92(4):313-8. PubMed ID: 26093189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IUDs and PID: understanding the American situation.
    Netw Res Triangle Park N C; 1987; 8(2):8. PubMed ID: 12268660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic characteristics of sexually transmitted infection/coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae.
    Cerkez-Habek J; Habek D
    Acta Med Croatica; 2001; 55(4-5):191-201. PubMed ID: 12398023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise and fall of IUDS's: banning of IUD's in USA. Alarming interactions between IUD's and sexually transmitted diseases (STD).
    Krzyzaniak LT; Lotfy M
    Adv Contracept Deliv Syst; 1986 Jun; 2(2-3):112-58. PubMed ID: 12280505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis infections using antigen detection methods.
    Stamm WE
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):93S-99S. PubMed ID: 3084162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.